MabCampath, myeloid cell types, inhibit, lymphocyte depletion, Lemtrada, Inhibitor, FcR, Campath-IH, B cells, Alemtuzumab, CD52, T cells
Alemtuzumab is a humanized monoclonal antibody targeting the CD52 antigen present on lymphocytes. It is widely used in research applications, including in vitro studies of lymphocyte depletion and in vivo models of autoimmune diseases and transplantation immunology.
Concentration:
10 mg/mL
Molecular Weight:
146.04 kDa
Purity:
98.00% (May vary between batches)
CAS Number:
[216503-57-0]
Target:
Others,Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted